CytRx (CYTR) Receives EPO Patent for Linker Platform; Giver 'Aldoxorubucin' Name to INNO-206

Go back to CytRx (CYTR) Receives EPO Patent for Linker Platform; Giver 'Aldoxorubucin' Name to INNO-206